New rapid test differentiates viral, bacterial infections

Article

Imagine if you had a quick and easy way to prove to a parent that their child?s illness was viral not bacterial, and that an antibiotic was not necessary. That day may be coming sooner than you think. Israel researchers have developed such a test that is time-saving, easy to perform and may soon be commercially available.

Imagine if you had a quick and easy way to prove to parents that their child’s illness was viral, not bacterial, and that an antibiotic was not necessary.

That day may be coming sooner than you think.

According to a report in the American Chemical Society’s journal Analytical Chemistry, scientists have developed and tested a rapid and accurate test to tell the difference between bacterial and viral infections.

In their study, Israeli researchers noted the problem that many pediatricians face: A bacterial infection can get worse if not treated with antibiotics but needlessly giving the drugs to patients with viral infections contributes to the growing problem of antibiotic resistance. Current tests are not only time-consuming but also are not always accurate.

Their test is based on how polymorphonuclear leukocytes or phagocytes respond during different types of infections.

"The method is time-saving, easy to perform and can be commercially available, thus, having predictive diagnostic value and could be implemented in various medical institutions as an adjunct to clinical decision making," according to researchers.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Related Content
© 2025 MJH Life Sciences

All rights reserved.